✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals
Market Cap
₹4,450 Cr.
P/E
42.69

Key Ratios

Market cap
Market cap
4,450 Cr
PE
PE
42.69
Prom Holding
Prom Holding
59.32 %
ROE (%)
ROE (%)
0.06
ROCE (%)
ROCE (%)
2.44
Div Yield (%)
Div Yield (%)
-
Sales
Sales
2,895 Cr
OPM (%)
OPM (%)
20.05 %
Debt to Equity
Debt to Equity
0.36

About

Dishman Carbogen Amcis Limited (DCAL) is a fully integrated CRAMS player in the pharmaceutical… Read more
Low
161
52W Range
High
322
  • Dishman Carbogen Amc
  • Sun Pharma Adv. Res
  • Zenotech Laboratorie
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Custom financial statement

New
Edit rows

Forensics

6 Yes

Positive for this company

1 Neutral

Neutral for this company

10 No

Negative for this company

0 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Segment Break-Up - Marketable Molecules

Location Wise Break-Up - Contract Research & Contract Manufacturing (CRAMS)

Location Wise Break-Up

Therapeutic Area Break-Up

Operating Profit Break-Up

Operational Metrics

    Select a Metric
    • US DMF Filings (.)
    • Total reactor capacity (kL)
    • R&D as a % of Total Sales (%)

    Peer Comparison

    Corporate Actions

    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less

    FAQs on Dishman Carbogen Amcis Ltd. Business

    Dishman Carbogen Amcis Limited is a fully integrated CRAMS player with global presence offering end-to-end services in process research, development, and manufacturing of Active Pharmaceutical Ingredients.

    Dishman Carbogen Amc major competitors are Sun Pharma Adv. Res, Zenotech Laboratorie, Vivo Bio Tech, Jeevan Scientific, Syngene Internation., Suven Life Sciences, Hikal.
    Market Cap of Dishman Carbogen Amc is ₹4,450 Crs.
    While the median market cap of its peers are ₹3,132 Crs.

    Dishman Carbogen Amc seems to be less financially stable compared to its competitors.
    Altman Z score of Dishman Carbogen Amc is 1.79 and is ranked 6 out of its 8 competitors.

    Company Filing

    Discussions & Analysis

    Ideas Dashboard
    Results
    Timeline
    Watchlist
    Portfolio
    Alerts
    Stock Screener
    Market
    Raw Material